REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 24 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,728 | +1290.7% | 18,242 | +1724.2% | 1.18% | +1130.2% |
| Q2 2023 | $1,059 | -73.5% | 1,000 | -69.2% | 0.10% | -71.4% |
| Q1 2023 | $4,001 | -99.6% | 3,249 | +224.9% | 0.34% | +360.3% |
| Q3 2022 | $1,085,000 | +34.1% | 1,000 | 0.0% | 0.07% | +25.9% |
| Q2 2022 | $809,000 | -14.9% | 1,000 | 0.0% | 0.06% | -6.5% |
| Q1 2022 | $951,000 | -79.3% | 1,000 | -80.7% | 0.06% | -82.7% |
| Q4 2021 | $4,587,000 | -33.7% | 5,187 | -13.6% | 0.36% | -49.4% |
| Q3 2021 | $6,920,000 | -70.6% | 6,000 | -70.1% | 0.71% | -67.6% |
| Q2 2021 | $23,535,000 | -15.0% | 20,087 | -18.3% | 2.18% | -19.6% |
| Q1 2021 | $27,677,000 | – | 24,587 | – | 2.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 20,087 | $23,535,000 | 2.18% |
| ZAZOVE ASSOCIATES LLC | 15,910,000 | $18,551,000 | 1.66% |
| SSI INVESTMENT MANAGEMENT LLC | 4,487,000 | $5,231,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,918,000 | $5,752,000 | 0.17% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 3,000,000 | $3,500,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 12,500,000 | $14,646,000 | 0.03% |
| Citadel Advisors | 104,329,000 | $122,081,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 20,000,000 | $23,433,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 2,918,000 | $3,416,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $56,240,000 | 0.02% |